Show pageBacklinksCite current pageExport to PDFBack to top This page is read only. You can view the source, but not change it. Ask your administrator if you think this is wrong. While endoluminal [[flow diverter]]s function from within the [[parent artery]] by providing a [[scaffold]] for [[endothelial cell]] growth at the [[aneurysm neck]] and induction of intra-aneurysmal [[thrombosis]] ((Kadirvel R, Ding YH, Dai D, Rezek I, Lewis DA, Kallmes DF. Cellular mechanisms of aneurysm occlusion after treatment with a flow diverter. Radiology. 2014;270(2):394-399.)) [[endosaccular device]]s mimic the endoluminal devices but within the aneurysmal sac itself. ((Ding YH, Lewis DA, Kadirvel R, Dai D, Kallmes DF. The Woven EndoBridge: a new aneurysm occlusion device. AJNR Am J Neuroradiol. 2011;32(3):607-611.)). ---- Several endosaccular flow disruptors have been developed, including the [[Woven EndoBridge]] (WEB; Microvention, Aliso Viejo, California), which was introduced in Europe in [[2011]], and [[Medina]] (Medtronic, Dublin, Ireland), Artisse (formerly LUNA; Medtronic) ((Munich, SA, Chen, M. Endovascular advances in the treatment of cerebral aneurysms: an overview of the development of new neuroendovascular techniques and technology for the treatment of cerebral aneurysms. Endovasc Today. 2017;2(16):66-70.)) ((Rajah G, Narayanan S, Rangel-Castilla L. Update on flow diverters for the endovascular management of cerebral aneurysms. Neurosurg Focus. 2017;42(6):E2.)) flow_disruptor.txt Last modified: 2024/06/07 02:56by 127.0.0.1